Distalmotion is a pioneering MedTech company established in 2012, based in Lausanne, Switzerland, with an additional U.S. office in Cleveland, Ohio. Its mission, encapsulated in the slogan "Empowering Access to Robotic Surgery_Right Robot, Right Site," is to make robotic surgery benefits more accessible globally, focusing on broadening availability in diverse medical settings like hospital outpatient departments and ambulatory surgical centers.
The company's flagship product, DEXTER, is a versatile robotic system designed for seamless integration into operating rooms of any size. It offers rapid setup and ease of movement, enhancing the efficiency of minimally invasive surgical procedures. DEXTER is already available for commercial use across the United States and Europe.
Recently, Distalmotion secured a substantial €136.94 million Series F investment from Revival Healthcare Capital, a notable indication of investor confidence in its innovative approach to healthcare technology.